# The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution

> **NCT00741156** · PHASE3 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 12 (actual)

## Conditions studied

- Hypertension
- Congestive Cardiomyopathy

## Interventions

- **DRUG:** Enalaprilat

## Key facts

- **NCT ID:** NCT00741156
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00741156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00741156, "The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00741156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*